nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Pemphigus—Lisinopril—dilated cardiomyopathy	0.0446	0.0473	CcSEcCtD
Carbidopa—Common cold—Lisinopril—dilated cardiomyopathy	0.0328	0.0347	CcSEcCtD
Carbidopa—Shoulder pain—Lisinopril—dilated cardiomyopathy	0.0317	0.0336	CcSEcCtD
Carbidopa—Leg pain—Lisinopril—dilated cardiomyopathy	0.0185	0.0196	CcSEcCtD
Carbidopa—Blister—Furosemide—dilated cardiomyopathy	0.0158	0.0168	CcSEcCtD
Carbidopa—Ataxia—Spironolactone—dilated cardiomyopathy	0.0143	0.0152	CcSEcCtD
Carbidopa—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.0139	0.0147	CcSEcCtD
Carbidopa—Fluid overload—Lisinopril—dilated cardiomyopathy	0.0137	0.0146	CcSEcCtD
Carbidopa—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.0137	0.0145	CcSEcCtD
Carbidopa—Gastritis—Spironolactone—dilated cardiomyopathy	0.0135	0.0143	CcSEcCtD
Carbidopa—Heartburn—Lisinopril—dilated cardiomyopathy	0.0124	0.0132	CcSEcCtD
Carbidopa—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0109	0.0116	CcSEcCtD
Carbidopa—Memory impairment—Lisinopril—dilated cardiomyopathy	0.0109	0.0115	CcSEcCtD
Carbidopa—Alopecia—Spironolactone—dilated cardiomyopathy	0.00929	0.00985	CcSEcCtD
Carbidopa—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00925	0.0098	CcSEcCtD
Carbidopa—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00916	0.00971	CcSEcCtD
Carbidopa—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0088	0.00933	CcSEcCtD
Carbidopa—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00865	0.00917	CcSEcCtD
Carbidopa—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00865	0.00917	CcSEcCtD
Carbidopa—Purpura—Furosemide—dilated cardiomyopathy	0.00858	0.0091	CcSEcCtD
Carbidopa—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00849	0.009	CcSEcCtD
Carbidopa—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.0083	0.0088	CcSEcCtD
Carbidopa—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.0083	0.0088	CcSEcCtD
Carbidopa—Malaise—Spironolactone—dilated cardiomyopathy	0.00826	0.00875	CcSEcCtD
Carbidopa—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00819	0.00869	CcSEcCtD
Carbidopa—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00807	0.00855	CcSEcCtD
Carbidopa—Urinary retention—Furosemide—dilated cardiomyopathy	0.00786	0.00834	CcSEcCtD
Carbidopa—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00775	0.00821	CcSEcCtD
Carbidopa—Discomfort—Spironolactone—dilated cardiomyopathy	0.0077	0.00816	CcSEcCtD
Carbidopa—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00755	0.00801	CcSEcCtD
Carbidopa—Confusional state—Spironolactone—dilated cardiomyopathy	0.00753	0.00799	CcSEcCtD
Carbidopa—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00745	0.00789	CcSEcCtD
Carbidopa—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00732	0.00775	CcSEcCtD
Carbidopa—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00717	0.0076	CcSEcCtD
Carbidopa—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00687	0.00729	CcSEcCtD
Carbidopa—Somnolence—Spironolactone—dilated cardiomyopathy	0.00664	0.00704	CcSEcCtD
Carbidopa—Pollakiuria—Furosemide—dilated cardiomyopathy	0.0066	0.007	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00645	0.00684	CcSEcCtD
Carbidopa—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00623	0.0066	CcSEcCtD
Carbidopa—Diplopia—Lisinopril—dilated cardiomyopathy	0.00621	0.00658	CcSEcCtD
Carbidopa—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00621	0.00658	CcSEcCtD
Carbidopa—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00616	0.00653	CcSEcCtD
Carbidopa—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00616	0.00653	CcSEcCtD
Carbidopa—Norepinephrine—SLC22A5—dilated cardiomyopathy	0.00602	0.107	CrCbGaD
Carbidopa—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00595	0.0063	CcSEcCtD
Carbidopa—Urticaria—Spironolactone—dilated cardiomyopathy	0.00594	0.00629	CcSEcCtD
Carbidopa—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00591	0.00626	CcSEcCtD
Carbidopa—Ataxia—Lisinopril—dilated cardiomyopathy	0.00584	0.00618	CcSEcCtD
Carbidopa—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00581	0.00616	CcSEcCtD
Carbidopa—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00567	0.00601	CcSEcCtD
Carbidopa—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00565	0.00599	CcSEcCtD
Carbidopa—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00561	0.00594	CcSEcCtD
Carbidopa—Dopamine—SLC22A5—dilated cardiomyopathy	0.0056	0.0991	CrCbGaD
Carbidopa—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00559	0.00592	CcSEcCtD
Carbidopa—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00555	0.00588	CcSEcCtD
Carbidopa—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0055	0.00583	CcSEcCtD
Carbidopa—Gastritis—Lisinopril—dilated cardiomyopathy	0.00549	0.00582	CcSEcCtD
Carbidopa—Epinephrine—SLC22A5—dilated cardiomyopathy	0.00546	0.0967	CrCbGaD
Carbidopa—Pruritus—Spironolactone—dilated cardiomyopathy	0.00529	0.0056	CcSEcCtD
Carbidopa—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00522	0.00554	CcSEcCtD
Carbidopa—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00511	0.00542	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00498	0.00528	CcSEcCtD
Carbidopa—Dizziness—Spironolactone—dilated cardiomyopathy	0.00494	0.00524	CcSEcCtD
Carbidopa—Droxidopa—ADRB1—dilated cardiomyopathy	0.00494	0.0875	CrCbGaD
Carbidopa—Flatulence—Furosemide—dilated cardiomyopathy	0.00491	0.0052	CcSEcCtD
Carbidopa—Weight increased—Lisinopril—dilated cardiomyopathy	0.00488	0.00517	CcSEcCtD
Carbidopa—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00488	0.00517	CcSEcCtD
Carbidopa—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00485	0.00514	CcSEcCtD
Carbidopa—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00479	0.00508	CcSEcCtD
Carbidopa—Depression—Lisinopril—dilated cardiomyopathy	0.00477	0.00505	CcSEcCtD
Carbidopa—Vomiting—Spironolactone—dilated cardiomyopathy	0.00475	0.00504	CcSEcCtD
Carbidopa—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00471	0.005	CcSEcCtD
Carbidopa—Rash—Spironolactone—dilated cardiomyopathy	0.00471	0.00499	CcSEcCtD
Carbidopa—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00471	0.00499	CcSEcCtD
Carbidopa—Vision blurred—Furosemide—dilated cardiomyopathy	0.00469	0.00498	CcSEcCtD
Carbidopa—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00469	0.00497	CcSEcCtD
Carbidopa—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00469	0.00497	CcSEcCtD
Carbidopa—Headache—Spironolactone—dilated cardiomyopathy	0.00468	0.00496	CcSEcCtD
Carbidopa—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00465	0.00493	CcSEcCtD
Carbidopa—Anaemia—Furosemide—dilated cardiomyopathy	0.0046	0.00488	CcSEcCtD
Carbidopa—Agitation—Furosemide—dilated cardiomyopathy	0.00458	0.00485	CcSEcCtD
Carbidopa—Isoprenaline—ADRB1—dilated cardiomyopathy	0.00449	0.0795	CrCbGaD
Carbidopa—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00446	0.00473	CcSEcCtD
Carbidopa—Leukopenia—Furosemide—dilated cardiomyopathy	0.00446	0.00473	CcSEcCtD
Carbidopa—Nausea—Spironolactone—dilated cardiomyopathy	0.00444	0.0047	CcSEcCtD
Carbidopa—Rhinitis—Lisinopril—dilated cardiomyopathy	0.0043	0.00456	CcSEcCtD
Carbidopa—Hallucination—Lisinopril—dilated cardiomyopathy	0.00427	0.00453	CcSEcCtD
Carbidopa—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00424	0.00449	CcSEcCtD
Carbidopa—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00421	0.00446	CcSEcCtD
Carbidopa—Norepinephrine—ADRB1—dilated cardiomyopathy	0.00416	0.0736	CrCbGaD
Carbidopa—Droxidopa—ADRB2—dilated cardiomyopathy	0.00415	0.0735	CrCbGaD
Carbidopa—Dry mouth—Furosemide—dilated cardiomyopathy	0.00415	0.0044	CcSEcCtD
Carbidopa—Confusional state—Furosemide—dilated cardiomyopathy	0.0041	0.00434	CcSEcCtD
Carbidopa—Shock—Furosemide—dilated cardiomyopathy	0.004	0.00424	CcSEcCtD
Carbidopa—Flushing—Lisinopril—dilated cardiomyopathy	0.00398	0.00422	CcSEcCtD
Carbidopa—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00398	0.00422	CcSEcCtD
Carbidopa—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00393	0.00417	CcSEcCtD
Carbidopa—Anorexia—Furosemide—dilated cardiomyopathy	0.00387	0.00411	CcSEcCtD
Carbidopa—Dopamine—ADRB1—dilated cardiomyopathy	0.00387	0.0684	CrCbGaD
Carbidopa—Hypotension—Furosemide—dilated cardiomyopathy	0.0038	0.00403	CcSEcCtD
Carbidopa—Alopecia—Lisinopril—dilated cardiomyopathy	0.00379	0.00402	CcSEcCtD
Carbidopa—Isoprenaline—ADRB2—dilated cardiomyopathy	0.00378	0.0669	CrCbGaD
Carbidopa—Epinephrine—ADRB1—dilated cardiomyopathy	0.00377	0.0668	CrCbGaD
Carbidopa—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00376	0.00399	CcSEcCtD
Carbidopa—Flatulence—Lisinopril—dilated cardiomyopathy	0.00368	0.0039	CcSEcCtD
Carbidopa—Tension—Lisinopril—dilated cardiomyopathy	0.00367	0.00389	CcSEcCtD
Carbidopa—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00366	0.00388	CcSEcCtD
Carbidopa—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00365	0.00387	CcSEcCtD
Carbidopa—Nervousness—Lisinopril—dilated cardiomyopathy	0.00363	0.00385	CcSEcCtD
Carbidopa—Back pain—Lisinopril—dilated cardiomyopathy	0.00361	0.00383	CcSEcCtD
Carbidopa—Somnolence—Furosemide—dilated cardiomyopathy	0.00361	0.00383	CcSEcCtD
Carbidopa—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00359	0.00381	CcSEcCtD
Carbidopa—Epinephrine—TNF—dilated cardiomyopathy	0.00358	0.0634	CrCbGaD
Carbidopa—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00353	0.00375	CcSEcCtD
Carbidopa—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00352	0.00373	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00351	0.00372	CcSEcCtD
Carbidopa—Fatigue—Furosemide—dilated cardiomyopathy	0.0035	0.00371	CcSEcCtD
Carbidopa—Tremor—Lisinopril—dilated cardiomyopathy	0.0035	0.00371	CcSEcCtD
Carbidopa—Norepinephrine—ADRB2—dilated cardiomyopathy	0.0035	0.0619	CrCbGaD
Carbidopa—Constipation—Furosemide—dilated cardiomyopathy	0.00348	0.00368	CcSEcCtD
Carbidopa—Pain—Furosemide—dilated cardiomyopathy	0.00348	0.00368	CcSEcCtD
Carbidopa—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00347	0.00368	CcSEcCtD
Carbidopa—Anaemia—Lisinopril—dilated cardiomyopathy	0.00345	0.00366	CcSEcCtD
Carbidopa—Angioedema—Lisinopril—dilated cardiomyopathy	0.00341	0.00362	CcSEcCtD
Carbidopa—Malaise—Lisinopril—dilated cardiomyopathy	0.00337	0.00357	CcSEcCtD
Carbidopa—Syncope—Lisinopril—dilated cardiomyopathy	0.00335	0.00355	CcSEcCtD
Carbidopa—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00335	0.00355	CcSEcCtD
Carbidopa—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00335	0.00355	CcSEcCtD
Carbidopa—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00332	0.00352	CcSEcCtD
Carbidopa—Palpitations—Lisinopril—dilated cardiomyopathy	0.0033	0.0035	CcSEcCtD
Carbidopa—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00328	0.00348	CcSEcCtD
Carbidopa—Cough—Lisinopril—dilated cardiomyopathy	0.00326	0.00346	CcSEcCtD
Carbidopa—Urticaria—Furosemide—dilated cardiomyopathy	0.00323	0.00342	CcSEcCtD
Carbidopa—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00321	0.00341	CcSEcCtD
Carbidopa—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00321	0.00341	CcSEcCtD
Carbidopa—Chest pain—Lisinopril—dilated cardiomyopathy	0.00318	0.00337	CcSEcCtD
Carbidopa—Epinephrine—ADRB2—dilated cardiomyopathy	0.00317	0.0562	CrCbGaD
Carbidopa—Anxiety—Lisinopril—dilated cardiomyopathy	0.00317	0.00336	CcSEcCtD
Carbidopa—Discomfort—Lisinopril—dilated cardiomyopathy	0.00314	0.00333	CcSEcCtD
Carbidopa—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00311	0.0033	CcSEcCtD
Carbidopa—Confusional state—Lisinopril—dilated cardiomyopathy	0.00308	0.00326	CcSEcCtD
Carbidopa—Oedema—Lisinopril—dilated cardiomyopathy	0.00305	0.00323	CcSEcCtD
Carbidopa—Infection—Lisinopril—dilated cardiomyopathy	0.00303	0.00321	CcSEcCtD
Carbidopa—Shock—Lisinopril—dilated cardiomyopathy	0.003	0.00318	CcSEcCtD
Carbidopa—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00299	0.00317	CcSEcCtD
Carbidopa—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00299	0.00317	CcSEcCtD
Carbidopa—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00295	0.00313	CcSEcCtD
Carbidopa—Asthenia—Furosemide—dilated cardiomyopathy	0.00292	0.00309	CcSEcCtD
Carbidopa—Anorexia—Lisinopril—dilated cardiomyopathy	0.00291	0.00308	CcSEcCtD
Carbidopa—Pruritus—Furosemide—dilated cardiomyopathy	0.00288	0.00305	CcSEcCtD
Carbidopa—Hypotension—Lisinopril—dilated cardiomyopathy	0.00285	0.00302	CcSEcCtD
Carbidopa—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00278	0.00295	CcSEcCtD
Carbidopa—Insomnia—Lisinopril—dilated cardiomyopathy	0.00276	0.00292	CcSEcCtD
Carbidopa—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00274	0.0029	CcSEcCtD
Carbidopa—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00272	0.00288	CcSEcCtD
Carbidopa—Somnolence—Lisinopril—dilated cardiomyopathy	0.00271	0.00287	CcSEcCtD
Carbidopa—Dizziness—Furosemide—dilated cardiomyopathy	0.00269	0.00285	CcSEcCtD
Carbidopa—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00268	0.00285	CcSEcCtD
Carbidopa—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00265	0.00281	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00263	0.00279	CcSEcCtD
Carbidopa—Fatigue—Lisinopril—dilated cardiomyopathy	0.00263	0.00279	CcSEcCtD
Carbidopa—Constipation—Lisinopril—dilated cardiomyopathy	0.00261	0.00276	CcSEcCtD
Carbidopa—Pain—Lisinopril—dilated cardiomyopathy	0.00261	0.00276	CcSEcCtD
Carbidopa—Vomiting—Furosemide—dilated cardiomyopathy	0.00258	0.00274	CcSEcCtD
Carbidopa—Rash—Furosemide—dilated cardiomyopathy	0.00256	0.00272	CcSEcCtD
Carbidopa—Dermatitis—Furosemide—dilated cardiomyopathy	0.00256	0.00271	CcSEcCtD
Carbidopa—Headache—Furosemide—dilated cardiomyopathy	0.00255	0.0027	CcSEcCtD
Carbidopa—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00251	0.00266	CcSEcCtD
Carbidopa—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00249	0.00264	CcSEcCtD
Carbidopa—Urticaria—Lisinopril—dilated cardiomyopathy	0.00242	0.00257	CcSEcCtD
Carbidopa—Nausea—Furosemide—dilated cardiomyopathy	0.00241	0.00256	CcSEcCtD
Carbidopa—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00241	0.00256	CcSEcCtD
Carbidopa—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00241	0.00256	CcSEcCtD
Carbidopa—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00225	0.00238	CcSEcCtD
Carbidopa—Asthenia—Lisinopril—dilated cardiomyopathy	0.00219	0.00232	CcSEcCtD
Carbidopa—Pruritus—Lisinopril—dilated cardiomyopathy	0.00216	0.00229	CcSEcCtD
Carbidopa—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00209	0.00221	CcSEcCtD
Carbidopa—Dizziness—Lisinopril—dilated cardiomyopathy	0.00202	0.00214	CcSEcCtD
Carbidopa—Vomiting—Lisinopril—dilated cardiomyopathy	0.00194	0.00206	CcSEcCtD
Carbidopa—Rash—Lisinopril—dilated cardiomyopathy	0.00192	0.00204	CcSEcCtD
Carbidopa—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00192	0.00204	CcSEcCtD
Carbidopa—Headache—Lisinopril—dilated cardiomyopathy	0.00191	0.00203	CcSEcCtD
Carbidopa—Nausea—Lisinopril—dilated cardiomyopathy	0.00181	0.00192	CcSEcCtD
